| 000 | 01891 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516235655.0 | ||
| 264 | 0 | _c20150611 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a2146-8427 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHan, Seungyeup | |
| 245 | 0 | 0 |
_aClinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis. _h[electronic resource] |
| 260 |
_bExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _cOct 2014 |
||
| 300 |
_a401-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aABO Blood-Group System _ximmunology |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Group Incompatibility _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Rejection _ximmunology |
| 650 | 0 | 4 |
_aGraft Survival _xdrug effects |
| 650 | 0 | 4 | _aHistocompatibility |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aIsoantibodies _xblood |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xsurgery |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlasmapheresis _xmethods |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Donors _xsupply & distribution |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHwang, Eunah | |
| 700 | 1 | _aPark, Sungbae | |
| 700 | 1 | _aPark, Uijun | |
| 700 | 1 | _aKim, Hyoungtae | |
| 700 | 1 | _aCho, Wonhyun | |
| 773 | 0 |
_tExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _gvol. 12 _gno. 5 _gp. 401-4 |
|
| 999 |
_c24263287 _d24263287 |
||